Skip to main content

Risk averse

By now it’s well documented that UW-Madison lags behind most of its peers in turning its esteemed research into marketable goods. The question is what would it take for the university to get on track and become a pacesetter in the lucrative development of pharmaceutical drugs and cutting-edge medical treatment? One answer: a “major culture change spearheaded by top leadership.”